CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin ...
Phase 2
Salt Lake City, Utah, United States and 23 other locations
escalation will be open to the enrollment of patients diagnosed with triple-negative breast cancer or ovarian cancer...
Phase 1
Salt Lake City, Utah, United States and 1 other location
to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0706 in patients with select advanced solid tumors...
Phase 1
West Valley City, Utah, United States of America and 20 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Salt Lake City, Utah, United States and 283 other locations
with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...
Phase 3
Salt Lake City, Utah, United States and 506 other locations
and tolerability of NKT5097 in adults with advanced/metastatic tumors (emphasis on breast cancer and solid tumors...
Phase 1
West Valley City, Utah, United States and 7 other locations
Researchers want to know if sacituzumab tirumotecan given alone or with pembrolizumab can treat triple negative breast cancer...
Phase 3
Salt Lake City, Utah, United States and 227 other locations
Phase 1/2, Open-label, Multi-center, First-in-human Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Anti-tumor Act...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 6 other locations
This study is to evaluate the safety and tolerability of JAB-2485 monotherapy in adult participants with advanced solid tumors....
Phase 1, Phase 2
Salt Lake City, Utah, United States and 7 other locations
to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received n...
Phase 3
Murray, Utah, United States and 265 other locations
Clinical trials
Research sites
Resources
Legal